Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT01307631
First received: March 1, 2011
Last updated: June 14, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)